Wolverine Trading’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$362K Sell
1,122
-1,316
-54% -$425K ﹤0.01% 748
2025
Q1
$655K Sell
2,438
-4,885
-67% -$1.31M ﹤0.01% 554
2024
Q4
$1.73M Buy
+7,323
New +$1.73M ﹤0.01% 390
2024
Q3
Hold
0
1330
2024
Q2
Hold
0
1254
2024
Q1
Sell
-2,946
Closed -$564K 1203
2023
Q4
$564K Buy
+2,946
New +$564K ﹤0.01% 639
2023
Q3
Hold
0
1174
2023
Q2
Hold
0
1094
2023
Q1
Sell
-1,323
Closed -$314K 1064
2022
Q4
$314K Buy
+1,323
New +$314K ﹤0.01% 590
2022
Q3
Sell
-2,997
Closed -$436K 1230
2022
Q2
$436K Buy
2,997
+1,425
+91% +$207K ﹤0.01% 575
2022
Q1
$260K Sell
1,572
-2,054
-57% -$340K ﹤0.01% 1062
2021
Q4
$620K Buy
3,626
+1,482
+69% +$253K ﹤0.01% 776
2021
Q3
$380K Sell
2,144
-4,622
-68% -$819K ﹤0.01% 1172
2021
Q2
$1.12M Buy
6,766
+2,394
+55% +$397K ﹤0.01% 572
2021
Q1
$591K Buy
4,372
+962
+28% +$130K ﹤0.01% 873
2020
Q4
$447K Buy
+3,410
New +$447K ﹤0.01% 893
2020
Q3
Hold
0
1240
2020
Q2
Hold
0
1279
2020
Q1
Sell
-5,440
Closed -$624K 1290
2019
Q4
$624K Buy
+5,440
New +$624K ﹤0.01% 799
2019
Q3
Sell
-7,356
Closed -$534K 1288
2019
Q2
$534K Buy
+7,356
New +$534K ﹤0.01% 581
2019
Q1
Sell
-13,618
Closed -$959K 1198
2018
Q4
$959K Sell
13,618
-12,860
-49% -$906K ﹤0.01% 426
2018
Q3
$2.32M Buy
+26,478
New +$2.32M 0.01% 257
2018
Q2
Hold
0
1392
2018
Q1
Sell
-10,288
Closed -$1.31M 1397
2017
Q4
$1.31M Buy
+10,288
New +$1.31M ﹤0.01% 476
2017
Q1
Sell
-9,069
Closed -$340K 1234
2016
Q4
$340K Buy
+9,069
New +$340K ﹤0.01% 717